AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33242112 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial nerve stimulation (FNS) group
Number of subjects: 29
Study 33242112 — intervention group
Group type: COMPARATOR
Intervention: Control group (without FNS)
Number of subjects: 29
Study 34353042 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention combined with respiratory functional exercises
Number of subjects: 150
Study 34353042 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 150
Study 32076917 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Daclatasvir (SOF/DCV) therapy for 12 weeks
Number of subjects: 30
Study 32076917 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Daclatasvir (SOF/DCV) therapy
Number of subjects: 30
Study 36018731 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruptive electronic alerts for PSA testing
Number of subjects: 10
Study 36018731 — intervention group
Group type: COMPARATOR
Intervention: Control group (no alerts)
Number of subjects: 10
Study 36018731 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruptive electronic alerts for various tests
Number of subjects: 10
Study 33866079 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study 34435831 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized normative feedback (PNF)
Number of subjects: 1188
Study 34435831 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1188
Study 34010505 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning through Play Plus (LTP+) added to treatment as usual (TAU)
Number of subjects: 774
Study 34010505 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 774
Study 32646509 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health Care Package (MHCP) implemented in 10 health facilities
Number of subjects: 37
Study 32646509 — intervention group
Group type: COMPARATOR
Intervention: Comparative control group (10 health facilities without MHCP)
Number of subjects: 37
Study 34382931 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive exercise (n=174) (six or fewer physiotherapy sessions)
Number of subjects: 708
Study 34382931 — intervention group
Group type: COMPARATOR
Intervention: Best-practice advice (n=174) (one physiotherapy session)
Number of subjects: 708
Study 34382931 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection then progressive exercise (n=182) (six or fewer physiotherapy sessions)
Number of subjects: 708
Study 34382931 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection then best-practice advice (n=178) (one physiotherapy session)
Number of subjects: 708
Study 35862479 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric resistance exercise
Number of subjects: 51
Study 35862479 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 51
Study 33104189 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Intermittent Bolus (RIB) therapy of hypertonic saline, 3%, for 24 to 48 hours
Number of subjects: 178
Study 33104189 — intervention group
Group type: COMPARATOR
Intervention: Slow Continuous Infusion (SCI) therapy of hypertonic saline, 3%, for 24 to 48 hours
Number of subjects: 178
Study 33977839 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC A (once daily for 1 week)
Number of subjects: 250
Study 33977839 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC B (twice daily for 1 week)
Number of subjects: 250
Study 33977839 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC C (once daily for 4 weeks)
Number of subjects: 250
Study 33977839 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC D (twice daily for 4 weeks)
Number of subjects: 250
Study 33977839 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific sham treatment)
Number of subjects: 250
Study 33594821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent TKI treatment (1 month ON and 1 month OFF)
Number of subjects: 166
Study 32803815 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Cancer and Living Meaningfully (CALM) therapy
Number of subjects: 206
Study 32803815 — intervention group
Group type: COMPARATOR
Intervention: Non‐manualized supportive psycho‐oncological counselling intervention (SPI)
Number of subjects: 206
Study 34414903 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg)
Number of subjects: 150
Study 34414903 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol (25 mg)
Number of subjects: 150
Study 34414903 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg) and metoprolol (25 mg) combination
Number of subjects: 150
Study 34414903 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 150
Study 33351303 — intervention group
Group type: COMPARATOR
Intervention: Testosterone Undecanoate Capsules (TUC) 40 mg, bid
Number of subjects: 200
Study 33351303 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiarong Tablets (JRT) + Testosterone Undecanoate Capsules (TUC) 0.92 g, tid
Number of subjects: 200
Study 35927649 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback reports providing information about routine data-based quality indicators (QIs) for gonarthrosis and/or coxarthrosis patients.
Number of subjects: 0
Study 35927649 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated network meetings for physicians.
Number of subjects: 0
Study 32539487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition test battery administered with a test-retest interval of ≥10 days
Number of subjects: 46
Study 32539487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition test battery administered with a test-retest interval of ≤5 days
Number of subjects: 46
Study 32539487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition test battery administered 4 times per day
Number of subjects: 46
Study 32539487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition test battery with test-retest interval affecting practice effects
Number of subjects: 46
Study 32539487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition test battery with unique stimulus sets
Number of subjects: 46
Study 34148927 — intervention group
Group type: EXPERIMENTAL
Intervention: myBeat device (n=150)
Number of subjects: 300
Study 34148927 — intervention group
Group type: COMPARATOR
Intervention: 24‐h Holter monitoring (control group; n=150)
Number of subjects: 300
Study 32889859 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based system supporting vestibulo-ocular reflex with oculomotor and optokinetic stimulus
Number of subjects: 20
Study 32889859 — intervention group
Group type: COMPARATOR
Intervention: Conventional vestibular rehabilitation
Number of subjects: 20
Study 36117554 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided caudal block (Group C)
Number of subjects: 0
Study 36117554 — intervention group
Group type: COMPARATOR
Intervention: US-guided femoral and sciatic nerve blocks (Group P)
Number of subjects: 0
Study 32212237 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg TID (3600 mg/day)
Number of subjects: 12
Study 32212237 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg TID)
Number of subjects: 12
Study 32212237 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 12
Study 32212237 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger money alternative ($1.50)
Number of subjects: 12
Study 36493691 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Electroconvulsive Therapy (ECT)
Number of subjects: 35
Study 36493691 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant treatment (Control)
Number of subjects: 35
Study 34238608 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBVAC
Number of subjects: 0
Study 34238608 — intervention group
Group type: COMPARATOR
Intervention: BCG
Number of subjects: 0
Study 32466473 — intervention group
Group type: COMPARATOR
Intervention: Thigh cuffs (potential countermeasure)
Number of subjects: 18
Study 32466473 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry immersion (DI)
Number of subjects: 18
Study 34040199 — intervention group
Group type: EXPERIMENTAL
Intervention: 5:2 intermittent energy restriction (IER)
Number of subjects: 16
Study 34040199 — intervention group
Group type: COMPARATOR
Intervention: Continuous energy restriction (CER)
Number of subjects: 16
Study 33245525 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental treatment in the presence of a therapy dog
Number of subjects: 102
Study 33245525 — intervention group
Group type: COMPARATOR
Intervention: Regular dental setup (control group)
Number of subjects: 102
Study 35782811 — intervention group
Group type: EXPERIMENTAL
Intervention: MRM with axillary lymphatic vessel ligation and quilting
Number of subjects: 120
Study 35782811 — intervention group
Group type: COMPARATOR
Intervention: Conventional modified radical mastectomy (MRM)
Number of subjects: 120
Study 32273943 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting
Number of subjects: 0
Study 32273943 — intervention group
Group type: EXPERIMENTAL
Intervention: SET8 overexpression
Number of subjects: 0
Study 32273943 — intervention group
Group type: EXPERIMENTAL
Intervention: PGC1α overexpression
Number of subjects: 0
Study 32273943 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo experiments
Number of subjects: 0
Study 34904238 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 200
Study 33007710 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 33
Study 33007710 — intervention group
Group type: COMPARATOR
Intervention: Lower Intensity Training (LIT)
Number of subjects: 33
Study 35950596 — intervention group
Group type: EXPERIMENTAL
Intervention: Group exercise intervention (twice a week for eight weeks)
Number of subjects: 40
Study 35950596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 33883862 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined education and skills intervention
Number of subjects: 255
Study 33883862 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge only intervention
Number of subjects: 255
Study 33883862 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral skills only intervention
Number of subjects: 255
Study 33883862 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 255
Study 34435439 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 0.56 mg/kg
Number of subjects: 121
Study 34435439 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (doses of 10, 25, 40, 55, or 70 μg/kg)
Number of subjects: 121
Study 34435439 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 34435439 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (doses of 0.125, 0.25, 0.5, 1.0, or 2.0 mg/kg)
Number of subjects: 121
Study 33052757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (40 mg/m2 weekly during RT)
Number of subjects: 298
Study 33052757 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 1 week before RT followed by 250 mg/m2/wk during RT)
Number of subjects: 298
Study 33052757 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose escalation in T3‐T4 tumors
Number of subjects: 298
Study 32343035 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar segmental stabilization exercises
Number of subjects: 26
Study 32343035 — intervention group
Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 26
Study 32343035 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 26
Study 35841521 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day PEG (2 L between 5:00 AM and 7:00 AM)
Number of subjects: 384
Study 35841521 — intervention group
Group type: COMPARATOR
Intervention: Split-dose PEG (1 L between 6:00 PM and 7:00 PM the day before and 1 L between 6:00 AM and 7:00 AM on the day of colonoscopy)
Number of subjects: 384
Study 35841521 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day PEG
Number of subjects: 384
Study 35841521 — intervention group
Group type: COMPARATOR
Intervention: Split-dose PEG
Number of subjects: 384
Study 33419917 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-sensitive intervention involving site-specific, modular, decentralised infrastructure to improve health by decreasing exposure to environmental faecal contamination.
Number of subjects: 144
Study 33419917 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no intervention initially, but will be offered intervention delivery after trial completion.
Number of subjects: 144
Study 33419917 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-sensitive intervention
Number of subjects: 144
Study 34328539 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (3,000 IU per day)
Number of subjects: 135
Study 34328539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 34050603 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced access to the Cochrane Handbook recommendations
Number of subjects: 2271
Study 34050603 — intervention group
Group type: COMPARATOR
Intervention: General link to the Cochrane Handbook (Control)
Number of subjects: 2271
Study 33176094 — intervention group
Group type: EXPERIMENTAL
Intervention: Early combination (vildagliptin+metformin)
Number of subjects: 39
Study 33176094 — intervention group
Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 39
Study 32053144 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell (MSC) therapy via transendocardial injections
Number of subjects: 34
Study 34229896 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus melatonin at a dose of 3 mg three times daily for 14 days
Number of subjects: 74
Study 34229896 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 74
Study 32312225 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible tip bougie
Number of subjects: 32
Study 32312225 — intervention group
Group type: COMPARATOR
Intervention: Standard bougie
Number of subjects: 32
Study 33356686 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise dose reduction (DR)
Number of subjects: 0
Study 33356686 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 34802917 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity and fall prevention intervention
Number of subjects: 0
Study 34802917 — intervention group
Group type: COMPARATOR
Intervention: Healthy eating intervention
Number of subjects: 0
Study 35248094 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based intervention package (slow breathing, Surya-namaskaram, mindfulness meditation)
Number of subjects: 584
Study 35248094 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 584
Study 32215805 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib mesylate 500–750 mg
Number of subjects: 105
Study 32660857 — intervention group
Group type: EXPERIMENTAL
Intervention: Online access to the educative platform (group B)
Number of subjects: 244
Study 32660857 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration of the platform and online access (group C)
Number of subjects: 244
Study 32660857 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration of the platform before using it (group C)
Number of subjects: 244
Study 32660857 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinical training (group A)
Number of subjects: 244
Study 36316706 — intervention group
Group type: EXPERIMENTAL
Intervention: Logo-therapy intervention (4 sessions of 45-60 min, three times a week)
Number of subjects: 80
Study 36316706 — intervention group
Group type: EXPERIMENTAL
Intervention: Logo-therapy intervention
Number of subjects: 80
Study 36316706 — intervention group
Group type: COMPARATOR
Intervention: Control group (no logo-therapy intervention)
Number of subjects: 80
Study 33912402 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR)
Number of subjects: 265
Study 33912402 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion (SC)
Number of subjects: 265
Study 33912402 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 265
Study 36016767 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral N-acetyl cysteine
Number of subjects: 64
Study 36016767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 32294257 — intervention group
Group type: EXPERIMENTAL
Intervention: Watershared incentive-based conservation program
Number of subjects: 129
Study 32294257 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 129
Study 35862138 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR screening
Number of subjects: 5997
Study 35862138 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 5997
Study 32216490 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg daily vaginal progesterone
Number of subjects: 85
Study 32216490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 32493502 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy behavior text messaging (daily)
Number of subjects: 0
Study 32493502 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure self‐monitoring (daily)
Number of subjects: 0
Study 32493502 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated primary care provider appointment scheduling (yes)
Number of subjects: 0
Study 32493502 — intervention group
Group type: COMPARATOR
Intervention: Healthy behavior text messaging (none)
Number of subjects: 0
Study 32493502 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure self‐monitoring (weekly)
Number of subjects: 0
Study 32493502 — intervention group
Group type: COMPARATOR
Intervention: Facilitated primary care provider appointment scheduling (no)
Number of subjects: 0
Study 36002117 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 5000 mg orally once daily from D 120 until parturition
Number of subjects: 16
Study 36002117 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 5000 mg orally twice daily from D 285 until parturition
Number of subjects: 16
Study 36002117 — intervention group
Group type: COMPARATOR
Intervention: Control group received 5000 mg lactose orally once daily from D 120 until parturition
Number of subjects: 16
Study 33103201 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos providing education about aging, ageism, and positive intergenerational contact
Number of subjects: 845
Study 33103201 — intervention group
Group type: COMPARATOR
Intervention: Education about wallpaper
Number of subjects: 845
Study 32044820 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg
Number of subjects: 105
Study 32044820 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone 100 mg
Number of subjects: 105
Study 32044820 — intervention group
Group type: COMPARATOR
Intervention: Eplerenone 50 mg
Number of subjects: 105
Study 36291258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar anodal tDCS
Number of subjects: 174
Study 36291258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar anodal and cathodal tDCS
Number of subjects: 174
Study 32524895 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Helping-Babies-Breathe training with video-debriefing
Number of subjects: 86
Study 32524895 — intervention group
Group type: COMPARATOR
Intervention: Standard Helping-Babies-Breathe training
Number of subjects: 86
Study 32780594 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Intervention (II; n = 40)
Number of subjects: 82
Study 32780594 — intervention group
Group type: COMPARATOR
Intervention: Delayed Intervention Control (DI; n = 42)
Number of subjects: 82
Study 36013495 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular single platelet-rich plasma (PRP)
Number of subjects: 110
Study 36013495 — intervention group
Group type: COMPARATOR
Intervention: Novel crosslinked hyaluronic acid (HA)
Number of subjects: 110
Study 33165057 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 50 U
Number of subjects: 120
Study 32106558 — intervention group
Group type: COMPARATOR
Intervention: Control group (Basic messages)
Number of subjects: 2115
Study 32106558 — intervention group
Group type: EXPERIMENTAL
Intervention: Care-Seeking (CS) message group
Number of subjects: 2115
Study 32106558 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Household Prenatal Practices (GHPP) message group
Number of subjects: 2115
Study 32106558 — intervention group
Group type: EXPERIMENTAL
Intervention: All Texts group
Number of subjects: 2115
Study 32106558 — intervention group
Group type: EXPERIMENTAL
Intervention: Care-Seeking message group
Number of subjects: 2115
Study 33765856 — intervention group
Group type: EXPERIMENTAL
Intervention: 5/0 polyester Ethibond (group A)
Number of subjects: 42
Study 33765856 — intervention group
Group type: COMPARATOR
Intervention: 5/0 Coated Vicryl® (polyglactin 910) (group B)
Number of subjects: 42
Study 33514479 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention, 5 sessions
Number of subjects: 41
Study 33514479 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 41
Study 35596166 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled Intraligamentary anaesthesia (CC-ILA)
Number of subjects: 50
Study 35596166 — intervention group
Group type: COMPARATOR
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 50
Study 33234777 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic jet oxygenation and ventilation (SJOV) using Wei nasal jet tube (WNJ)
Number of subjects: 280
Study 33234777 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannula oxygenation (NCO)
Number of subjects: 280
Study 33234777 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic jet oxygenation and ventilation (SJOV)
Number of subjects: 280
Study 34907594 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg Remimazolam Tosilate (R1)
Number of subjects: 99
Study 34907594 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg Remimazolam Tosilate (R2)
Number of subjects: 99
Study 34907594 — intervention group
Group type: COMPARATOR
Intervention: Propofol (P)
Number of subjects: 99